Management of Migraine-Associated Vestibulocochlear Disorders.
Level 5 - mechanism / opinion, no new human data
Narrative review and expert opinion proposing a clinical management algorithm.
PubMed 37489383 · doi:10.3390/audiolres13040047
What was done
Narrative review and expert synthesis examining the epidemiological and pathophysiological associations between migraine and vestibulocochlear symptoms (including vertigo, tinnitus, hearing loss, and dizziness). The authors present a management algorithm based on literature and clinical observations.
What was found
The abstract reports no numerical findings or statistical measures. It describes qualitative treatment recommendations comprising first-line lifestyle and dietary modifications alongside supplements (vitamin B2 and magnesium), followed by migraine prophylactic medications (nortriptyline, topiramate, verapamil) for refractory symptoms.
Why it matters
It highlights vestibulocochlear disorders as underdiagnosed manifestations of migraine and offers a practical clinical framework for stepwise management.
Limits
As a narrative review and expert opinion paper, it lacks empirical data, quantitative outcomes, control groups, or systematic search methodology in the abstract.
Cited by
- supports Magnesium supplementation, alongside B vitamins and CoQ10, is effective in alleviating migraine symptoms and associated tinnitus or dizziness exacerbations.